GERRESHEIMER AG (GXI.DE) Fundamental Analysis & Valuation

FRA:GXI • DE000A0LD6E6

Current stock price

18.56 EUR
-0.81 (-4.18%)
Last:

This GXI.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. GXI.DE Profitability Analysis

1.1 Basic Checks

  • In the past year GXI was profitable.
  • In the past year GXI had a positive cash flow from operations.
  • In the past 5 years GXI has always been profitable.
  • In the past 5 years GXI always reported a positive cash flow from operatings.
GXI.DE Yearly Net Income VS EBIT VS OCF VS FCFGXI.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

  • GXI's Return On Assets of 0.50% is on the low side compared to the rest of the industry. GXI is outperformed by 83.33% of its industry peers.
  • With a Return On Equity value of 1.67%, GXI is not doing good in the industry: 77.78% of the companies in the same industry are doing better.
  • GXI has a Return On Invested Capital of 2.79%. This is amonst the worse of the industry: GXI underperforms 83.33% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for GXI is below the industry average of 9.09%.
Industry RankSector Rank
ROA 0.5%
ROE 1.67%
ROIC 2.79%
ROA(3y)3.04%
ROA(5y)3.09%
ROE(3y)7.67%
ROE(5y)8.3%
ROIC(3y)6.14%
ROIC(5y)6.08%
GXI.DE Yearly ROA, ROE, ROICGXI.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • GXI has a worse Profit Margin (1.04%) than 83.33% of its industry peers.
  • GXI's Profit Margin has been stable in the last couple of years.
  • The Operating Margin of GXI (5.99%) is worse than 83.33% of its industry peers.
  • In the last couple of years the Operating Margin of GXI has grown nicely.
  • GXI's Gross Margin of 26.89% is on the low side compared to the rest of the industry. GXI is outperformed by 72.22% of its industry peers.
  • GXI's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 5.99%
PM (TTM) 1.04%
GM 26.89%
OM growth 3Y-0.21%
OM growth 5Y2.69%
PM growth 3Y-1.23%
PM growth 5Y-1.47%
GM growth 3Y0.37%
GM growth 5Y1.38%
GXI.DE Yearly Profit, Operating, Gross MarginsGXI.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. GXI.DE Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so GXI is destroying value.
  • The number of shares outstanding for GXI remains at a similar level compared to 1 year ago.
  • Compared to 5 years ago, GXI has more shares outstanding
  • Compared to 1 year ago, GXI has a worse debt to assets ratio.
GXI.DE Yearly Shares OutstandingGXI.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
GXI.DE Yearly Total Debt VS Total AssetsGXI.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

  • Based on the Altman-Z score of 0.91, we must say that GXI is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 0.91, GXI is doing worse than 77.78% of the companies in the same industry.
  • A Debt/Equity ratio of 1.22 is on the high side and indicates that GXI has dependencies on debt financing.
  • With a Debt to Equity ratio value of 1.22, GXI is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.22
Debt/FCF N/A
Altman-Z 0.91
ROIC/WACC0.37
WACC7.61%
GXI.DE Yearly LT Debt VS Equity VS FCFGXI.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

  • A Current Ratio of 0.98 indicates that GXI may have some problems paying its short term obligations.
  • GXI has a Current ratio of 0.98. This is in the lower half of the industry: GXI underperforms 72.22% of its industry peers.
  • GXI has a Quick Ratio of 0.98. This is a bad value and indicates that GXI is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.52, GXI is not doing good in the industry: 77.78% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.98
Quick Ratio 0.52
GXI.DE Yearly Current Assets VS Current LiabilitesGXI.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. GXI.DE Growth Analysis

3.1 Past

  • GXI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -19.08%.
  • The Earnings Per Share has been decreasing by -8.23% on average over the past years.
  • GXI shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.83%.
  • GXI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.90% yearly.
EPS 1Y (TTM)-19.08%
EPS 3Y4.26%
EPS 5Y-8.23%
EPS Q2Q%-39.66%
Revenue 1Y (TTM)11.83%
Revenue growth 3Y10.77%
Revenue growth 5Y7.9%
Sales Q2Q%12.47%

3.2 Future

  • The Earnings Per Share is expected to grow by 3.46% on average over the next years.
  • GXI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.99% yearly.
EPS Next Y-54.12%
EPS Next 2Y-25.19%
EPS Next 3Y-8.21%
EPS Next 5Y3.46%
Revenue Next Year12.69%
Revenue Next 2Y7.49%
Revenue Next 3Y6.85%
Revenue Next 5Y6.99%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
GXI.DE Yearly Revenue VS EstimatesGXI.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1B 2B 3B
GXI.DE Yearly EPS VS EstimatesGXI.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

6

4. GXI.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 5.03, which indicates a rather cheap valuation of GXI.
  • 100.00% of the companies in the same industry are more expensive than GXI, based on the Price/Earnings ratio.
  • Compared to an average S&P500 Price/Earnings ratio of 25.60, GXI is valued rather cheaply.
  • The Price/Forward Earnings ratio is 7.09, which indicates a rather cheap valuation of GXI.
  • GXI's Price/Forward Earnings ratio is rather cheap when compared to the industry. GXI is cheaper than 100.00% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of GXI to the average of the S&P500 Index (22.84), we can say GXI is valued rather cheaply.
Industry RankSector Rank
PE 5.03
Fwd PE 7.09
GXI.DE Price Earnings VS Forward Price EarningsGXI.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, GXI is valued cheaply inside the industry as 94.44% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.71
GXI.DE Per share dataGXI.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

  • A cheap valuation may be justified as GXI's earnings are expected to decrease with -8.21% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-25.19%
EPS Next 3Y-8.21%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. GXI.DE Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.19%, GXI is not a good candidate for dividend investing.
  • In the last 3 months the price of GXI has falen by -33.24%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
  • Compared to an average industry Dividend Yield of 0.52, GXI is paying slightly less dividend.
  • Compared to an average S&P500 Dividend Yield of 1.88, GXI's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.19%

5.2 History

  • The dividend of GXI has a limited annual growth rate of 0.94%.
Dividend Growth(5Y)0.94%
Div Incr Years0
Div Non Decr Years6
GXI.DE Yearly Dividends per shareGXI.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • 10.12% of the earnings are spent on dividend by GXI. This is a low number and sustainable payout ratio.
  • The dividend of GXI is growing, but earnings are growing more, so the dividend growth is sustainable.
DP10.12%
EPS Next 2Y-25.19%
EPS Next 3Y-8.21%
GXI.DE Yearly Income VS Free CF VS DividendGXI.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M
GXI.DE Dividend Payout.GXI.DE Dividend Payout, showing the Payout Ratio.GXI.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

GXI.DE Fundamentals: All Metrics, Ratios and Statistics

GERRESHEIMER AG

FRA:GXI (4/2/2026, 7:00:00 PM)

18.56

-0.81 (-4.18%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-26
Earnings (Next)04-16
Inst Owners91.76%
Inst Owner ChangeN/A
Ins Owners4.92%
Ins Owner ChangeN/A
Market Cap641.06M
Revenue(TTM)2.25B
Net Income(TTM)23.35M
Analysts53.04
Price Target32.54 (75.32%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.19%
Yearly Dividend1.32
Dividend Growth(5Y)0.94%
DP10.12%
Div Incr Years0
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.39%
Min EPS beat(2)-6.69%
Max EPS beat(2)1.92%
EPS beat(4)3
Avg EPS beat(4)7.96%
Min EPS beat(4)-6.69%
Max EPS beat(4)18.84%
EPS beat(8)5
Avg EPS beat(8)4.68%
EPS beat(12)8
Avg EPS beat(12)3.75%
EPS beat(16)9
Avg EPS beat(16)2.33%
Revenue beat(2)0
Avg Revenue beat(2)-1.48%
Min Revenue beat(2)-2.11%
Max Revenue beat(2)-0.85%
Revenue beat(4)0
Avg Revenue beat(4)-1.32%
Min Revenue beat(4)-2.11%
Max Revenue beat(4)-0.72%
Revenue beat(8)1
Avg Revenue beat(8)-0.95%
Revenue beat(12)3
Avg Revenue beat(12)-0.89%
Revenue beat(16)6
Avg Revenue beat(16)-0.27%
PT rev (1m)-6.02%
PT rev (3m)-15.6%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-211.42%
EPS NY rev (1m)-25.78%
EPS NY rev (3m)-30.66%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)0.62%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.3%
Valuation
Industry RankSector Rank
PE 5.03
Fwd PE 7.09
P/S 0.28
P/FCF N/A
P/OCF 2.53
P/B 0.46
P/tB N/A
EV/EBITDA 6.71
EPS(TTM)3.69
EY19.88%
EPS(NY)2.62
Fwd EY14.11%
FCF(TTM)-2.51
FCFYN/A
OCF(TTM)7.34
OCFY39.56%
SpS65.15
BVpS40.59
TBVpS-8.95
PEG (NY)N/A
PEG (5Y)N/A
Graham Number58.05
Profitability
Industry RankSector Rank
ROA 0.5%
ROE 1.67%
ROCE 3.76%
ROIC 2.79%
ROICexc 2.93%
ROICexgc 5.89%
OM 5.99%
PM (TTM) 1.04%
GM 26.89%
FCFM N/A
ROA(3y)3.04%
ROA(5y)3.09%
ROE(3y)7.67%
ROE(5y)8.3%
ROIC(3y)6.14%
ROIC(5y)6.08%
ROICexc(3y)6.5%
ROICexc(5y)6.42%
ROICexgc(3y)14.47%
ROICexgc(5y)16.32%
ROCE(3y)8.29%
ROCE(5y)8.2%
ROICexgc growth 3Y-17.1%
ROICexgc growth 5Y-18.13%
ROICexc growth 3Y-1.3%
ROICexc growth 5Y1.06%
OM growth 3Y-0.21%
OM growth 5Y2.69%
PM growth 3Y-1.23%
PM growth 5Y-1.47%
GM growth 3Y0.37%
GM growth 5Y1.38%
F-Score4
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 1.22
Debt/FCF N/A
Debt/EBITDA 4.4
Cap/Depr 134.54%
Cap/Sales 15.12%
Interest Coverage 1.65
Cash Conversion 65.42%
Profit Quality N/A
Current Ratio 0.98
Quick Ratio 0.52
Altman-Z 0.91
F-Score4
WACC7.61%
ROIC/WACC0.37
Cap/Depr(3y)167.14%
Cap/Depr(5y)152.09%
Cap/Sales(3y)15.92%
Cap/Sales(5y)14.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-19.08%
EPS 3Y4.26%
EPS 5Y-8.23%
EPS Q2Q%-39.66%
EPS Next Y-54.12%
EPS Next 2Y-25.19%
EPS Next 3Y-8.21%
EPS Next 5Y3.46%
Revenue 1Y (TTM)11.83%
Revenue growth 3Y10.77%
Revenue growth 5Y7.9%
Sales Q2Q%12.47%
Revenue Next Year12.69%
Revenue Next 2Y7.49%
Revenue Next 3Y6.85%
Revenue Next 5Y6.99%
EBIT growth 1Y-34.26%
EBIT growth 3Y10.54%
EBIT growth 5Y10.8%
EBIT Next Year81.16%
EBIT Next 3Y29.65%
EBIT Next 5Y20.08%
FCF growth 1Y-1073.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-11.63%
OCF growth 3Y4.26%
OCF growth 5Y4.49%

GERRESHEIMER AG / GXI.DE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of GERRESHEIMER AG (GXI.DE) stock?

ChartMill assigns a fundamental rating of 3 / 10 to GXI.DE.


What is the valuation status for GXI stock?

ChartMill assigns a valuation rating of 6 / 10 to GERRESHEIMER AG (GXI.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for GERRESHEIMER AG?

GERRESHEIMER AG (GXI.DE) has a profitability rating of 3 / 10.


Can you provide the PE and PB ratios for GXI stock?

The Price/Earnings (PE) ratio for GERRESHEIMER AG (GXI.DE) is 5.03 and the Price/Book (PB) ratio is 0.46.


How financially healthy is GERRESHEIMER AG?

The financial health rating of GERRESHEIMER AG (GXI.DE) is 0 / 10.